
Select M&As involving U.S. and European biotech companies 2022
During 2022, U.S. company Amgen acquired Irish-U.S. company Horizon Therapeutics with a potential value of some 27.8 billion U.S. dollars. This statistic shows the total potential value of select mergers and acquisitions involving U.S. and/or European biotechnology companies.